Evidence map›Paper›PMID 18035569›Full record

ReviewProstaglandins & other lipid mediators2008

Sphingolipids and membrane biology as determined from genetic models.

Raghavendra Pralhada Rao, Jairaj K Acharya

Abstract readReview
In one paragraph

Review in Prostaglandins & other lipid mediators, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Ganglioside biochemistry.ISRN biochemistry · 2012
    Review
  12. Article
  13. Ceramide transfer protein and cancer.Anti-cancer agents in medicinal chemistry · 2011
    Review
  14. Article
  15. Distribution and functions of sterols and sphingolipids.Cold Spring Harbor perspectives in biology · 2011
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Raghavendra Pralhada RaoLaboratory of Cell and Developmental Signaling, National Cancer Institute Frederick, MD 21702, USA.
Jairaj K Acharya
National Cancer Institute · US

Funding

PHOSPHOLIPID AND SPHINGOLIPID SIGNALING IN DROSOPHILAZ01BC010331 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ACHARYA, JAIRAJ · 2000 to 2008
$1.9M
Intramural NIH HHS Z01 BC010331Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

The importance of sphingolipids in membrane biology was appreciated early in the twentieth century when several human inborn errors of metabolism were linked to defects in sphingolipid degradation. The past two decades have seen an explosion of information linking sphingolipids with cellular processes. Studies have unraveled mechanistic details of the sphingolipid metabolic pathways, and these findings are being exploited in the development of novel therapies, some now in clinical trials. Pioneering work in yeast has laid the foundation for identifying genes encoding the enzymes of the pathways. The advent of the era of genomics and bioinformatics has led to the identification of homologous genes in other species and the subsequent creation of animal knock-out lines for these genes. Discoveries from these efforts have re-kindled interest in the role of sphingolipids in membrane biology. This review highlights some of the recent advances in understanding sphingolipids' roles in membrane biology as determined from genetic models.

Indexed as

Models, GeneticAnimalsCell MembraneEndocytosisExocytosisHumansLigandsReceptors, Cell SurfaceSphingolipidsLigandsReceptors, Cell SurfaceSphingolipids

Identifiers

PMID18035569
PMCPMC2242731
OpenAlexW2039457497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.